当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析

华森制药

(002907)

  

流通市值:51.65亿  总市值:69.82亿
流通股本:3.09亿   总股本:4.18亿

华森制药(002907)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.003-3112-3109-3006-3000.30.60.90.060.120.180.24
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.40亿元,每股收益0.10元。

股东权益 + 未分配利润
Created with Highcharts 9.1.003-3112-3109-3006-300612186.46.87.27.6
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益170049.71万元,未分配利润72198.68万元。

总资产 + 负债
Created with Highcharts 9.1.003-3112-3109-3006-300816242.22.42.62.8
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产195356.24万元,负债25306.53万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入238,944,153.42774,819,866.89614,223,361.57417,852,265.17
营业总成本189,330,193.11699,830,140.66534,304,062.41361,848,490.3
营业利润49,521,445.8993,800,589.589,054,863.3857,638,953.68
利润总额49,301,337.6293,441,938.6988,672,868.8157,200,244.27
净利润40,355,212.3876,730,225.1274,576,835.6347,214,896.12
其他综合收益-6,070.86244,061.74-173,845.46101,866.35
综合收益总额40,349,141.5276,974,286.8674,402,990.1747,316,762.47
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,091,355,563.011,031,344,511.281,013,977,367.68958,850,580.15
非流动资产合计862,206,829.46886,205,077.72897,738,929.78916,988,241
资产总计1,953,562,392.471,917,549,5891,911,716,297.461,875,838,821.15
流动负债合计209,944,378.22212,034,140.92207,532,333.4189,733,906.52
非流动负债合计43,120,927.1545,517,169.746,906,649.5741,447,626.02
负债合计253,065,305.37257,551,310.62254,438,982.97231,181,532.54
归属于母公司股东权益合计1,700,497,087.11,659,998,278.381,657,277,314.491,644,657,288.61
股东权益合计1,700,497,087.11,659,998,278.381,657,277,314.491,644,657,288.61
负债和股东权益合计1,953,562,392.471,917,549,5891,911,716,297.461,875,838,821.15
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计191,675,253.51799,973,405.6592,150,956.57392,933,932.67
经营活动现金流出小计169,814,310.46638,206,596.58485,270,379.52328,175,950.96
经营活动产生的现金流量净额21,860,943.05161,766,809.02106,880,577.0564,757,981.71
投资活动现金流入小计121,203,411.52348,531,606.4214,694,231.323,621,625.89
投资活动现金流出小计302,374,756.73455,741,063.7452,000,526.19207,237,680.87
投资活动产生的现金流量净额-181,171,345.21-107,209,457.3-237,306,294.89-183,616,054.98
筹资活动现金流入小计----
筹资活动现金流出小计28,80035,634,044.7235,634,044.7220,980,015.7
筹资活动产生的现金流量净额-28,800-35,634,044.72-35,634,044.72-20,980,015.7
汇率变动对现金及现金等价物的影响-136,374.9563,769.26-45,680.8826,460.87
现金及现金等价物净增加额-159,475,577.1118,987,076.26-166,105,443.44-139,811,628.1
期末现金及现金等价物余额297,077,352.27456,551,895.4271,459,375.7297,753,191.04
TOP↑